Focal Interest
Focal Interest
AI Summary of Peer-Reviewed Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Publishing process signals: MODERATE — reflects the venue and review process. — venue and review process.

Paternal valproate use was not linked to child neurodevelopmental disorders

A split-view photograph showing medication bottles and medical supplies on the left side and a blurred person viewing a computer screen on the right side, depicting a medical research or healthcare documentation scenario.
Research area:MedicinePediatrics, Perinatology and Child HealthPharmacological Effects and Toxicity Studies

What the study found

Paternal use of valproate within the 90 days before conception was not associated with an increased risk of neurodevelopmental disorders (NDDs, conditions affecting brain development and function) in offspring after confounding was adjusted for.

Why the authors say this matters

The authors do not give a detailed explanation of importance in the abstract beyond reporting the finding. The study suggests that the adjusted results from Norwegian and Taiwanese cohorts may be relevant to understanding the relationship between paternal valproate use and child neurodevelopmental outcomes.

What the researchers tested

The researchers examined paternal valproate use within the 90 days before conception and its association with neurodevelopmental disorders in children. They used Norwegian and Taiwanese cohort data and adjusted for confounding factors.

What worked and what didn't

After adjustment for confounding, the study found no increased risk of NDDs in offspring associated with paternal valproate use in the preconception window. The abstract does not report any positive association or subgroup-specific result.

What to keep in mind

The abstract provides limited detail on study design, specific confounders, outcomes, or limitations. No limitations are described in the available summary.

Key points

  • Paternal valproate use within 90 days before conception was not linked to increased NDD risk in offspring after adjustment.
  • The finding was reported for both Norwegian and Taiwanese cohorts.
  • The abstract does not describe a detailed rationale, subgroup results, or specific limitations.

Disclosure

Research title:
Paternal valproate use was not linked to child neurodevelopmental disorders
Authors:
Lin-Chieh Meng, Marleen M. H. J. van Gelder, Hui-Min Chuang, HC Lai, Li Chen, Fei-Yuan Hsiao, Hedvig M E Nordeng
Institutions:
National Taiwan University, University of Oslo, University of Pennsylvania, National Yang Ming Chiao Tung University, Taipei Veterans General Hospital, Taipei Municipal YangMing Hospital, National Taiwan University Hospital, Norwegian Institute of Public Health
Publication date:
2026-02-24
DOI:
10.1056/evidoa2500254
OpenAlex record:
View
AI provenance: This post was generated by OpenAI. The original authors did not write or review this post.

More posts